Atara Biotherapeutics, Inc. (ATRA)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
Feb 20, 16:00
4.17
-0.01
(-0.24%)
After-Hours: 20:00
Atara Biotherapeutics Total Assets (Quarterly) : 30.17M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Pfizer Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| AbbVie, Inc. | 133.96B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.80M |
| Shareholders Equity (Quarterly) | -36.63M |
| Debt to Equity Ratio | -1.600 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | 6.05% |